We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+1.73%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$8.15B
AUM Growth
-$196M
Cap. Flow
+$80.8M
Cap. Flow %
0.99%
Top 10 Hldgs %
27.57%
Holding
587
New
39
Increased
187
Reduced
142
Closed
42

Top Buys

Rank Stock Value
1
DG icon
Dollar General
DG
+$51.2M
2
HES
Hess
HES
+$50.3M
3
ABT icon
Abbott
ABT
+$49.2M
4
PGR icon
Progressive
PGR
+$41.9M
5
MSFT icon
Microsoft
MSFT
+$32.1M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$65.3M
2
PCAR icon
PACCAR
PCAR
+$65M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$41.5M
4
BIIB icon
Biogen
BIIB
+$38.5M
5
TPR icon
Tapestry
TPR
+$23M

Sector Composition

Rank Sector Weight
1 Technology 36.17%
2 Healthcare 14.32%
3 Financials 13.21%
4 Communication Services 10.05%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOVA icon
476
Iovance Biotherapeutics
IOVA
$4.24B
$251K ﹤0.01%
34,000
RXRX icon
477
Recursion Pharmaceuticals
RXRX
$1.74B
$248K ﹤0.01%
33,500
ADPT icon
478
Adaptive Biotechnologies
ADPT
$4.26B
$225K ﹤0.01%
35,700
AFG icon
479
American Financial Group
AFG
$11.9B
$219K ﹤0.01%
1,600
-200
-11% -$27.5K
VIR icon
480
Vir Biotechnology
VIR
$1.77B
$215K ﹤0.01%
28,800
IBB icon
481
iShares Biotechnology ETF
IBB
$10.3B
$211K ﹤0.01%
39,000
GRFS
482
Grifois
GRFS
$5.01B
$207K ﹤0.01%
27,056
BCYC
483
Bicycle Therapeutics
BCYC
$257M
$204K ﹤0.01%
14,000
ABCL icon
484
AbCellera Biologics
ABCL
$3.7B
$185K ﹤0.01%
62,000
NUE icon
485
Nucor
NUE
$58.7B
$184K ﹤0.01%
1,590
-8,342
-84% -$1.2M
RIO icon
486
Rio Tinto
RIO
$158B
$176K ﹤0.01%
3,000
MAIN icon
487
Main Street Capital
MAIN
$5.29B
$176K ﹤0.01%
3,028
+85
+3% +$4.53K
FAF icon
488
First American
FAF
$7.44B
$175K ﹤0.01%
2,800
-400
-13% -$26.1K
SU icon
489
Suncor Energy
SU
$84.1B
$169K ﹤0.01%
4,800
-12,500
-72% -$481K
SAGE
490
DELISTED
Sage Therapeutics
SAGE
$158K ﹤0.01%
28,500
MRVI icon
491
Maravai LifeSciences
MRVI
$1.03B
$156K ﹤0.01%
28,400
ARE icon
492
Alexandria Real Estate Equities
ARE
$9.11B
$147K ﹤0.01%
1,500
-600
-29% -$65.8K
REPL icon
493
Replimune Group
REPL
$1.23B
$146K ﹤0.01%
11,900
ICLN icon
494
iShares Global Clean Energy ETF
ICLN
$2.08B
$140K ﹤0.01%
300,000
SEDG icon
495
SolarEdge
SEDG
$2.17B
$133K ﹤0.01%
9,733
-181,472
-95% -$2.79M
SBAC icon
496
SBA Communications
SBAC
$19.4B
$122K ﹤0.01%
600
-500
-45% -$113K
GRAL
497
GRAIL Inc
GRAL
$3.39B
$120K ﹤0.01%
6,168
RLAY icon
498
Relay Therapeutics
RLAY
$4.16B
$101K ﹤0.01%
23,100
RTX icon
499
RTX Corp
RTX
$263B
$97.4K ﹤0.01%
845
RGNX icon
500
Regenxbio
RGNX
$525M
$96.3K ﹤0.01%
13,000

Similar funds

Erste Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Erste Asset Management held 587 positions worth $8.15B, down 2.4% from $8.35B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Erste Asset Management's Q4 2024 filing shows 39 new, 187 increased, 142 reduced and 42 closed positions. Its largest new stake was Dollar General: 650,000 shares worth $49.2M. The largest sale was Netflix, an estimated $65.3M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.

  • Erste Asset Management's largest Q4 2024 buy was Dollar General: 650,000 shares worth $49.2M.
  • Erste Asset Management added most to Abbott in Q4 2024, an estimated $49.2M increase.
  • Erste Asset Management's biggest Q4 2024 reduction was Netflix, cutting an estimated $65.3M.
  • Erste Asset Management fully exited PetIQ, Inc. Class A Common Stock in Q4 2024, selling an estimated $13.3M.
  • Erste Asset Management's ten largest holdings make up 28% of its $8.15B portfolio in Q4 2024.
  • Erste Asset Management opened 39 new positions and closed 42 in Q4 2024.
  • Erste Asset Management's portfolio value fell 2.4% quarter-over-quarter to $8.15B.

Based on Erste Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.